Ikko Kashiwagi

Ikko Kashiwagi

Auto-generated profile, based on publicly available information

Ikko Kashiwagi

Department of Microbiology and Immunology, Department of Internal Medicine, Keio University School of Medicine, Tokyo 160-8582, Japan, and Japan Science and Technology Agency, CREST, Tokyo 102-0076, Japan

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2011 in Arteriosclerosis, Thrombosis, and Vascular Biology
Verified
Journal Article
Closed access
TTTaiga Tamiya
Taiga Tamiya
IKIkko Kashiwagi
Ikko Kashiwagi
RTReiko Takahashi
Reiko Takahashi
HYHideo Yasukawa
Hideo Yasukawa
AYAkihiko Yoshimura
Akihiko Yoshimura
Various cytokines are involved in the regulation of the immune system and inflammation. Dysregulation of cytokine signaling can cause a variety of diseases, including allergy, autoimmune diseases, inflammation, and cancer. Most cytokines use the so-called janus kinase/signal transducer and activator of transcription pathway, and this pathway is negatively regulated by suppressors of cytokine signaling (SOCS) proteins. SOCS proteins bind to janus kinase and to certain cytokine receptors and signaling molecules, thereby suppressing further signaling events. Studies have shown that SOCS proteins are key physiological regulators of inflammation. Recent studies have also demonstrated that SOCS1 and SOCS3 are important regulators of adaptive immunity.

20 January 2013 in Nature Immunology
Verified
Journal Article
Closed access
TSTakashi Sekiya
Takashi Sekiya
IKIkkou Kashiwagi
Ikkou Kashiwagi
RYRei Yoshida
Rei Yoshida
TFTomohiro Fukaya
Tomohiro Fukaya
RMRimpei Morita
Rimpei Morita
AYAkihiko Yoshimura
Akihiko Yoshimura

5 April 2011 in Nature Communications
Verified
Journal Article
Open access
TSTakashi Sekiya
Takashi Sekiya
IKIkkou Kashiwagi
Ikkou Kashiwagi
NINaoko Inoue
Naoko Inoue
RMRimpei Morita
Rimpei Morita
SHShohei Hori
Shohei Hori
AYAkihiko Yoshimura
Akihiko Yoshimura
Regulatory T cells (Tregs) have a central role in maintaining immune homoeostasis through various mechanisms. Although the Forkhead transcription factor Foxp3 defines the Treg cell lineage and functions, the molecular mechanisms of Foxp3 induction and maintenance remain elusive. Here we show that Foxp3 is one of the direct targets of Nr4a2. Nr4a2 binds to regulatory regions of Foxp3, where it mediates permissive histone modifications. Ectopic expression of Nr4a2 imparts Treg-like suppressive activity to naïve CD4(+) T cells by inducing Foxp3 and by repressing cytokine production, including interferon-γ and interleukin-2. Deletion of Nr4a2 in T cells attenuates induction of Tregs and causes aberrant induction of Th1, leading to the exacerbation of colitis. Nr4a2-deficeint Tregs are prone to lose Foxp3 expression and have attenuated suppressive ability both in vitro and in vivo. Thus, Nr4a2 has the ability to maintain T-cell homoeostasis by regulating induction, maintenance and suppressor functions of Tregs, and by repression of aberrant Th1 induction.

1 July 2015 in Immunity
Verified
Journal Article
Closed access
IKIkkou Kashiwagi
Ikkou Kashiwagi
RMRimpei Morita
Rimpei Morita
TSTakashi Schichita
Takashi Schichita
KKKyoko Komai
Kyoko Komai
KSKeita Saeki
Keita Saeki
AYAkihiko Yoshimura
Akihiko Yoshimura

1 May 2011 in Immunity
Verified
Journal Article
Closed access
KIKenji Ichiyama
Kenji Ichiyama
TSTakashi Sekiya
Takashi Sekiya
NINaoko Inoue
Naoko Inoue
TTTaiga Tamiya
Taiga Tamiya
IKIkko Kashiwagi
Ikko Kashiwagi
AYAkihiko Yoshimura
Akihiko Yoshimura

1 September 2011 in Cancer Letters
Verified
Journal Article
Closed access
KHKiyokazu Hiwatashi
Kiyokazu Hiwatashi
TTTaiga Tamiya
Taiga Tamiya
EHEiichi Hasegawa
Eiichi Hasegawa
TFTomohiro Fukaya
Tomohiro Fukaya
MHMasayuki Hashimoto
Masayuki Hashimoto
AYAkihiko Yoshimura
Akihiko Yoshimura